Brussels, Belgium

Decio Laks Eizirik

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Centre National De La Recherche Scientifique, Ecole Superieure De Physique Et De Chimie Industrielles De La Ville De Paris, National Institute of Health and Medical Research. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Decio Laks Eizirik. Retrieved from https://idiyas.com/inventor/decio-laks-eizirik

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Decio Laks Eizirik: Innovator in Diabetes Research

Introduction

Decio Laks Eizirik is a prominent inventor based in Brussels, Belgium. He has made significant contributions to the field of diabetes research, particularly in the development of diagnostic and therapeutic methods for Type 1 diabetes. His innovative work has garnered attention in the scientific community.

Latest Patents

Eizirik holds a patent titled "Antigenic Peptides Deriving from Secretogranin V and Uses Thereof for the Diagnosis and Treatment of Type 1 Diabetes." This patent represents a crucial advancement in understanding and potentially treating this chronic condition. He has 1 patent to his name.

Career Highlights

Throughout his career, Eizirik has worked with esteemed institutions such as Inserm (Institut National de la Santé et de la Recherche Médicale) and Université de Paris. His research has focused on the mechanisms underlying Type 1 diabetes and the development of novel therapeutic strategies.

Collaborations

Eizirik has collaborated with notable colleagues, including Roberto Mallone and Joëlle Vinh. These partnerships have enhanced his research efforts and contributed to the advancement of diabetes treatment.

Conclusion

Decio Laks Eizirik is a key figure in diabetes research, with a focus on innovative solutions for Type 1 diabetes. His contributions through patents and collaborations continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…